Trials / Conditions / Anal, Colon, and Rectal Cancers
Anal, Colon, and Rectal Cancers
3 registered clinical trials studyying Anal, Colon, and Rectal Cancers.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors NCT01137162 | Stanford University | — |
| Completed | Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer NCT00532909 | Branimir Sikic | Phase 1 |
| Withdrawn | Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer NCT00780988 | Stanford University | Phase 1 |